Page last updated: 2024-11-05

butonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

butonate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31343
CHEMBL ID1570266
CHEBI ID82106
SCHEMBL ID117990
MeSH IDM0049642

Synonyms (88)

Synonym
brn 1813429
o,o-dimethyl-(1-n-butyryloxy-2,2,2-trichloraethyl)-phosphonsaeureester
dimethyl 2,2,2-trichloro-1-n-butyryloxyethylphosphonate
einecs 204-778-4
o,o-dimethyl-2,2,2-trichloro-1-phosphonoethyl butyrate
butonate [iso]
pedix-butonate
dimethyl (2,2,2-trichloro-1-butyryloxyethyl)phosphonate
fekama at 50
butonatum [inn-latin]
dimethyl 1-butyryloxy-2,2,2-trichloroethylphosphonate
butyric acid, ester with dimethyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate
nsc 17872
epa pesticide chemical code 035701
butonato [inn-spanish]
phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester, butyrate
ent 20,852
o,o-dimethyl-(1-butyryloxy-2,2,2-trichloroethyl) phosphonate
2,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl butanoate
butonat [german]
pedix pe 50
o,o-dimethyl-2,2,2-trichloro-1-n-butyryloxyethyl phosphonate
dimethyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate butyric acid ester
o,o-dimethyl (2,2,2-trichloro-1-n-butyryloxyethyl)phosphonate
o,o-dimethyl (2,2,2-trichloro-1-hydroxyethyl) phosphonate ester of butyric acid
caswell no. 385a
f 139
pedix-50
dimethoxy-2,2,2-trichloro-1-n-butyryloxy-ethylphospine oxide
hsdb 1595
ai3-20852
D03194
butonate (usan/inn)
butanoic acid,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester
dimethyl (2,2-trichloro-1-hydroxyethyl)phosphonate ester of butyric acid
dimethoxy-2,2-trichloro-1-n-butyryloxy-ethylphosphine oxide
butyric acid,2,2-trichloro-1-hydroxyethyl)phosphonate
ent-20852
butonate
o,2,2-trichloro-1-n-butyryloxyethyl)phosphonate
0,2,2-trichloro-1-(n-butyryloxy)ethylphosphonate
butyric acid ester of dimethyl (2,2-trichloro-1-hydroxyethyl)phosphonate
tribufon
butanoic acid 2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester
phosphonic acid,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester, butyrate
126-22-7
wln: gxggyov3 & po & o1 & o1
f-139
dimethyl 2,2-trichloro-1-n-butyryloxyethylphosphonate
nsc-17872
t-113 ,
dimethyl 2,2-trichloro-1-butyryloxyethylphosphonate
butilchlorofos
nsc17872
(2,2,2-trichloro-1-dimethoxyphosphoryl-ethyl) butanoate
BUT ,
butanoic acid, 2,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester
2,2,2-trichloro-1-(dimethoxyphosphoryl)ethyl butyrate
0, 0-dimethyl 2,2,2-trichloro-1-(n-butyryloxy)ethylphosphonate
butanoic acid 2,2,2-trichloro-1-(dimethoxyphosphinyl)ethyl ester
NCGC00160570-01
(2,2,2-trichloro-1-dimethoxyphosphorylethyl) butanoate
butonato
unii-39m9r3q494
butonat
39m9r3q494 ,
butonate [usan:inn]
butonatum
C18967
dtxcid3021697
cas-126-22-7
tox21_111908
dtxsid5041697 ,
AKOS024332382
trichlorfon butanoic acid ester
chebi:82106 ,
CHEMBL1570266
SCHEMBL117990
butonate [hsdb]
butonate [inn]
(rs)-2,2,2-trichloro-1-(dimethoxyphosphinoyl)ethyl butyrate
butonate [usan]
trichlorfon butanoic acid ester [mi]
butonate [green book]
BKAQXYNWONVOAX-UHFFFAOYSA-N
Q27155753
DB11379
o,o-dimethyl 2,2,2-trichloro-1-butyryloxyethylphosphonate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
fatty acid esterA carboxylic ester in which the carboxylic acid component can be any fatty acid.
butyrate esterAny carboxylic ester where the carboxylic acid component is butyric acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency0.11890.000811.382244.6684AID686979
AR proteinHomo sapiens (human)Potency20.75100.000221.22318,912.5098AID743040; AID743053
estrogen nuclear receptor alphaHomo sapiens (human)Potency16.63070.000229.305416,493.5996AID743069; AID743075; AID743079; AID743080; AID743091
aryl hydrocarbon receptorHomo sapiens (human)Potency33.49150.000723.06741,258.9301AID743085; AID743122
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency0.00630.00798.23321,122.0200AID2551
lamin isoform A-delta10Homo sapiens (human)Potency35.48130.891312.067628.1838AID1487
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency63.09570.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (63.64)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.93 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index138.47 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (46.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]